Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Irem Y. Özbek"'
Autor:
Sandro C. Esteves, Hakan Yarali, Lan N. Vuong, José F. Carvalho, İrem Y. Özbek, Mehtap Polat, Ho L. Le, Toan D. Pham, Tuong M. Ho
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
ObjectiveTo estimate the prevalence of low-prognosis patients according to the POSEIDON criteria using real-world data.DesignMulticenter population-based cohort study.SettingsFertility clinics in Brazil, Turkey, and Vietnam.PatientsInfertile women un
Externí odkaz:
https://doaj.org/article/05372fa51281439fb12561f08cd23712
Autor:
Sandro C. Esteves, Hakan Yarali, Filippo M. Ubaldi, José F. Carvalho, Fabiola C. Bento, Alberto Vaiarelli, Danilo Cimadomo, İrem Y. Özbek, Mehtap Polat, Gurkan Bozdag, Laura Rienzi, Carlo Alviggi
Publikováno v:
Frontiers in Endocrinology, Vol 10 (2020)
This multicenter study evaluated the reliability of the recently published ART calculator for predicting the minimum number of metaphase II (MII) oocytes (MIImin) to obtain at least one euploid blastocyst in patients undergoing in vitro fertilization
Externí odkaz:
https://doaj.org/article/6b69d963f37f435fabf2acb5a925594a
Autor:
Sandro C. Esteves, Carlo Alviggi, Peter Humaidan, Robert Fischer, Claus Y. Andersen, Alessandro Conforti, Klaus Bühler, Sesh K. Sunkara, Nikolaos P. Polyzos, Daniela Galliano, Michael Grynberg, Hakan Yarali, Irem Y. Özbek, Matheus Roque, Lan N. Vuong, Manish Banker, Laura Rienzi, Alberto Vaiarelli, Danilo Cimadomo, Filippo M. Ubaldi
Publikováno v:
Frontiers in Endocrinology, Vol 10 (2019)
This article represents a viewpoint on the POSEIDON criteria by a group of clinicians and embryologists. Its primary objective is to contextualize the Poseidon criteria and their metric of success for the relevant Frontiers Research Topic “POSEIDON
Externí odkaz:
https://doaj.org/article/0d58f41d39ab42e594682ed738a7772f
Autor:
Gurkan Bozdag, İrem Y Özbek, Mehtap Polat, Hakan Yarali, Murat Erden, Sezcan Mumusoglu, Peter Humaidan
Publikováno v:
Yarali, H, Polat, M, Mumusoglu, S, Ozbek, I Y, Erden, M, Bozdag, G & Humaidan, P 2021, ' Subcutaneous luteal phase progesterone rescue rectifies ongoing pregnancy rates in hormone replacement therapy vitrified–warmed blastocyst transfer cycles ', Reproductive BioMedicine Online, vol. 43, no. 1, pp. 45-51 . https://doi.org/10.1016/j.rbmo.2021.04.011
Research question: Will luteal phase rescue with additional progesterone increase serum progesterone concentrations and improve reproductive outcomes in patients with low serum progesterone concentrations undergoing hormone replacement therapy (HRT)
Autor:
Lale Karakoc Sokmensuer, Hakan Yarali, İrem Y Özbek, Mehtap Polat, Gurkan Bozdag, Sezcan Mumusoglu
Publikováno v:
Reproductive BioMedicine Online. 42:892-900
To assess incidence of abnormal cleavage among biopsied blastocysts; to compare euploidy rates of the blastocysts with abnormal and normal cleavage; and to compare single euploid blastocyst transfer (SEBT) outcome derived from embryos with normal or
Autor:
Sandro C. Esteves, Mehtap Polat, Hakan Yarali, José F Carvalho, Tuong M Ho, Ho L Le, Toan D Pham, Lan N. Vuong, İrem Y Özbek
Publikováno v:
Human Reproduction. 36:1530-1541
STUDY QUESTION What is the agreement between antral follicle count (AFC) and anti-Müllerian hormone (AMH) levels when used to patient classification according to the Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number (POSEIDON) cr
Autor:
Ho L Le, Lan N. Vuong, Peter Humaidan, José F Carvalho, Carlo Alviggi, Toan D Pham, Hakan Yarali, Sandro C. Esteves, Tuong M Ho, İrem Y Özbek, Mehtap Polat
Publikováno v:
Esteves, S C, Yarali, H, Vuong, L N, Carvalho, J F, Özbek, İ Y, Polat, M, Le, H L, Pham, T D, Ho, T M, Humaidan, P & Alviggi, C 2021, ' Cumulative delivery rate per aspiration IVF/ICSI cycle in POSEIDON patients : a real-world evidence study of 9073 patients ', Human Reproduction, vol. 36, no. 8, pp. 2157-2169 . https://doi.org/10.1093/humrep/deab152
Human Reproduction (Oxford, England)
Human Reproduction (Oxford, England)
STUDY QUESTION What is the cumulative delivery rate (CDR) per aspiration IVF/ICSI cycle in low-prognosis patients as defined by the Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number (POSEIDON) criteria? SUMMARY ANSWER The CDR of P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::038f2431c1f0304aea5ee3960c2eeaa9
https://pure.au.dk/ws/files/274021732/deab152.pdf
https://pure.au.dk/ws/files/274021732/deab152.pdf
Publikováno v:
Polat, M, Mumusoglu, S, Bozdag, G, Ozbek, I Y, Humaidan, P & Yarali, H 2020, ' Addition of intramuscular progesterone to vaginal progesterone in hormone replacement therapy in vitrified–warmed blastocyst transfer cycles ', Reproductive BioMedicine Online, vol. 40, no. 6, pp. 812-818 . https://doi.org/10.1016/j.rbmo.2020.01.031
Research question: Does intramuscular progesterone supplementation ensure ongoing pregnancy rates (OPR) comparable with vaginal progesterone only in hormone replacement therapy cycles for vitrified–warmed embryo transfer; and is there a window of s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65d3307848145fd1fcdd55e4e0e31b49
https://pure.au.dk/portal/da/publications/addition-of-intramuscular-progesterone-to-vaginal-progesterone-in-hormone-replacement-therapy-in-vitrifiedwarmed-blastocyst-transfer-cycles(057df7b7-b5fa-46b5-bd7b-173e87dd5828).html
https://pure.au.dk/portal/da/publications/addition-of-intramuscular-progesterone-to-vaginal-progesterone-in-hormone-replacement-therapy-in-vitrifiedwarmed-blastocyst-transfer-cycles(057df7b7-b5fa-46b5-bd7b-173e87dd5828).html
Autor:
José F Carvalho, Hakan Yarali, İrem Y Özbek, Filippo Maria Ubaldi, Alessandro Conforti, Alberto Vaiarelli, Danilo Cimadomo, Sandro C. Esteves, Carlo Alviggi, Thor Haahr, Peter Humaidan
Publikováno v:
Esteves, S C, Humaidan, P, Carvalho, J F, Cimadomo, D, Vaiarelli, A, Yarali, H, Ozbek, I Y, Haahr, T, Conforti, A, Alviggi, C & Ubaldi, F M 2019, ' Blastocyst ploidy is not related to the number of embryos generated nor to the type of ovarian stimulation ', Fertility and Sterility, vol. 112, no. 3, pp. E134-E134 . https://doi.org/10.1016/j.fertnstert.2019.07.470
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0943cc0876a75d4e5a2d04d48f9aab1
https://pure.au.dk/portal/da/publications/blastocyst-ploidy-is-not-related-to-the-number-of-embryos-generated-nor-to-the-type-of-ovarian-stimulation(a760c6c1-1043-4038-a845-a092d30ba131).html
https://pure.au.dk/portal/da/publications/blastocyst-ploidy-is-not-related-to-the-number-of-embryos-generated-nor-to-the-type-of-ovarian-stimulation(a760c6c1-1043-4038-a845-a092d30ba131).html
Autor:
Mehtap Polat, Hakan Yarali, Lale Karakoc Sokmensuer, Zuhal Yapici Coskun, Sezcan Mumusoglu, İrem Y Özbek, Gurkan Bozdag
Publikováno v:
Reproductive biomedicine online. 39(1)
Does preimplantation genetic testing for aneuploidy (PGT-A) influence the discontinuation rate in women with advanced maternal age (AMA) undergoing IVF?Retrospective longitudinal cohort study carried out at a single IVF clinic in Turkey. In total, 40